NCT01232686

Brief Summary

The study investigates whether shared online access to epidemiological data for general practitioners, disease prevention officers, emergency care services and microbiology laboratories changes clinical practice with regard to testing, diagnosing and treatment of communicable diseases. The main hypothesis is that "online access for general practitioner to epidemiological data about communicable diseases changes clinical practice for testing, diagnosing and treatment of communicable diseases".

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2010

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2010

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 2, 2010

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

February 16, 2017

Status Verified

December 1, 2015

Enrollment Period

2.2 years

First QC Date

October 15, 2010

Last Update Submit

February 15, 2017

Conditions

Keywords

Communicable DiseasesEpidemiologyPopulation surveillanceComputerized Medical RecordData collection

Outcome Measures

Primary Outcomes (1)

  • Earlier diagnosis and treatment for communicable diseases

    General practitioners (GP) have three possible decisions in a consultation with a patient; 1) treat on suspicion, 2) take a sample, 3) wait and see whether the patient recovers or get worse, or 4) a combination of 1 and 2. In situations with decision 3 (wait and see) the patient may return to a consultation later on. The hypothesis is that online access to epidemiological data from the local patient population will enable GPs to make the right decision more often based on knowledge about the epidemiological situation in the patient population.

    Measured at the end of the data collection period, approx. 1.5 year. (December 2012)

Secondary Outcomes (3)

  • Earlier detection of local disease outbreaks

    Measured at the end of the data collection period, approx. 1.5 year. (December 2012)

  • Lower number of infected during disease outbreaks

    Measured at the end of the data collection period, approx. 1.5 year. (December 2012)

  • Impact on health service costs

    Measured at the end of the data collection period, approx. 1.5 year. (December 2012)

Study Arms (2)

Control area

NO INTERVENTION

In the control areas we will monitor the prevalence and treatment of communicable diseases without giving the participants online access to disease surveillance information

Intervention area

EXPERIMENTAL

In these areas we will give study participants online access to epidemiological data for communicable diseases

Other: Online disease surveillance data access

Interventions

In the intervention areas we will give the study participants online access to the Snow disease surveillance system. The system will provide data about the incidents of respiratory and gastrointestinal communicable diseases in the patient population.

Intervention area

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteering General Practitioner (GP) working in a GP office

You may not qualify if:

  • The GP does not use a Electronic Patient Record (EPR) system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Communicable Diseases

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Johan Gustav Bellika, PhD

    University of Tromsø, Department of Computer Science

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2010

First Posted

November 2, 2010

Study Start

October 1, 2010

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

February 16, 2017

Record last verified: 2015-12